Other / Other / MRI

Bell palsy

Rapid onset unilateral lower motor neuron facial paralysis presenting acutely over hours to days with uncertain etiology, requiring imaging when atypical features are present or surgical planning is considered.
Look For First
  • Smooth, uniform linear enhancement of the facial nerve extending from the internal auditory canal through the tympanic and mastoid segments
  • Asymmetry comparing enhanced affected side to the contralateral normal side—enhancement is more intense on the affected nerve
  • Focal enhancement in the lateral aspect of the internal auditory meatus as a marker of severity
Key Image Findings
  • Long segments of the facial nerve show uniform linear enhancement that is more intense than the contralateral non-affected side on post-contrast MRI, though enhancement is absent in 0-43% of cases.
  • The most frequent site of involvement is on either side of the geniculate ganglion, extending from the distal internal auditory canal to the distal tympanic segment.
  • Mastoid and extratemporal segments show less frequent involvement but should be assessed for completeness.
  • Normal facial nerve enhancement pattern includes the geniculate ganglion and mastoid segments on both sides; enhancement on the affected side exceeds the contralateral pattern.
  • Focal enhancement at the most lateral aspect of the internal auditory meatus has been proposed as a marker of disease severity and prognostic indicator.
  • Nodularity or focal bulging of the enhanced nerve should raise suspicion for neoplastic infiltration rather than idiopathic Bell palsy.
  • Leptomeningeal enhancement in remote areas, particularly in the cerebellopontine angle or internal auditory canal, suggests alternative etiologies such as neurosarcoidosis or perineural spread.
  • MRI enhancement may persist for up to one year after clinical improvement, so presence of enhancement does not exclude resolution.
Differential Diagnosis
  • Ramsay Hunt syndrome (herpes zoster oticus)—presents with vesicular rash in external auditory canal or auricle, often with more severe palsy and worse prognosis than Bell palsy.
  • Perineural spread of malignancy—characterized by nodularity or thickening of the facial nerve rather than smooth uniform enhancement, often with involvement of multiple cranial nerves.
  • Neurosarcoidosis—demonstrates leptomeningeal enhancement along the facial nerve pathway and remote meningeal enhancement, often affecting multiple cranial nerves.
  • Facial nerve hemangioma—shows characteristic homogeneous enhancement on a mass basis rather than diffuse linear nerve enhancement.
  • Guillain-Barré syndrome—involves multiple peripheral nerves bilaterally with enhancement that is typically multifocal and symmetric.
  • Lyme disease—may cause Bell palsy but is typically bilateral and associated with CSF pleocytosis and serology confirmation.
Discussion

Bell palsy is a diagnosis of exclusion requiring typical clinical presentation (acute unilateral lower motor neuron facial paralysis) because numerous serious conditions can mimic it, particularly perineural tumor spread, neurosarcoidosis, and Ramsay Hunt syndrome.

The pathophysiology remains incompletely understood, with leading theories including HSV-1 reactivation, immune-mediated mechanisms, microvascular ischemia, or anatomical compression at the internal auditory canal.

MRI has limited but important clinical utility and should be reserved for atypical presentations (slow progression, spasm before paralysis, multiple cranial nerves, recurrent episodes, or no recovery after 6-8 weeks) or when surgical decompression is contemplated.

Enhancement of the facial nerve in Bell palsy is neither sensitive nor specific—it occurs in only 57-100% of cases and can persist for up to one year after full clinical recovery, making it potentially misleading if interpreted without clinical correlation.

Risk factors including diabetes, depression, increasing age, and hypothyroidism predict higher risk of Bell palsy and should influence clinical suspicion; males and females are equally affected.

Prognosis is favorable with 70-90% full recovery especially with early corticosteroid treatment within 72 hours, but 4-7% experience recurrence, typically 10 years later, emphasizing the need for long-term follow-up awareness.

Reporting Pearls

Describe facial nerve enhancement as "smooth, uniform linear enhancement of the [right/left] facial nerve from the internal auditory canal through the tympanic and mastoid segments, more intense than the contralateral side, consistent with Bell palsy when clinical presentation is typical." Always compare directly to the contralateral side, note if enhancement is absent, and explicitly search for nodularity or remote leptomeningeal enhancement to exclude alternative etiologies.

Pitfalls
  • Mistaking normal bilateral geniculate ganglion and mastoid segment enhancement for pathologic Bell palsy enhancement—always compare asymmetry rather than assuming any enhancement is abnormal.
  • Absence of facial nerve enhancement does not exclude Bell palsy since 0-43% of cases show no enhancement; absence of enhancement does not improve or worsen the diagnosis.
  • Overlooking nodularity or irregular morphology of the enhanced nerve, which should prompt investigation for perineural spread, hemangioma, or neoplastic infiltration instead of accepting Bell palsy diagnosis.
  • Failing to assess multiple cranial nerves and remote meningeal regions, which when involved suggest neurosarcoidosis, Lyme disease, or lymphoma rather than isolated idiopathic Bell palsy.